Literature DB >> 25588817

Human 3-hydroxyanthranilate 3,4-dioxygenase () dynamics and reaction, a multilevel computational study.

H Brkić1, B Kovačević, S Tomić.   

Abstract

3-Hydroxyanthranilate 3,4-dioxygenase () is a non-heme iron dependent enzyme. It catalyses the cleavage of the benzene ring of 3-hydroxyanthranilic acid (3-Ohaa), an intermediate in the kynurenine pathway, and therefore represents a potential target in treating numerous disorders related to the concentration of quinolinic acid (QUIN), the kynurenine pathway product, in tissues. The stability and behaviour of the enzyme in nearly physiological conditions, studied by the empirical molecular modelling methods enabled us to determine the influence of several, for the enzyme activity relevant, point mutations (Arg43Ala, Arg95Ala and Glu105Ala) on the protein structure, particularly on the active site architecture and the metal ion environment, as well as on the substrate, 3-Ohaa, binding. Besides, the water population of the active site, and the protein flexibility as well as the amino acid residues interaction networks relevant for the enzyme activity were determined for the 3-Ohaa complexes with the native and mutated enzyme variants. Finally, using the hybrid quantum-mechanics/molecular-mechanics (QM/MM) calculations the catalysed 3-Ohaa oxidation into 2-amino-3-carboxymuconic acid semialdehyde was elucidated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25588817     DOI: 10.1039/c4mb00668b

Source DB:  PubMed          Journal:  Mol Biosyst        ISSN: 1742-2051


  4 in total

Review 1.  Mono- and binuclear non-heme iron chemistry from a theoretical perspective.

Authors:  Tibor András Rokob; Jakub Chalupský; Daniel Bím; Prokopis C Andrikopoulos; Martin Srnec; Lubomír Rulíšek
Journal:  J Biol Inorg Chem       Date:  2016-05-26       Impact factor: 3.358

Review 2.  Protein effects in non-heme iron enzyme catalysis: insights from multiscale models.

Authors:  Nathalie Proos Vedin; Marcus Lundberg
Journal:  J Biol Inorg Chem       Date:  2016-06-30       Impact factor: 3.358

3.  New cases that expand the genotypic and phenotypic spectrum of Congenital NAD Deficiency Disorder.

Authors:  Justin O Szot; Anne Slavotinek; Karen Chong; Oliver Brandau; Marjan Nezarati; Anna M Cueto-González; Millan S Patel; Walter P Devine; Shannon Rego; Alicia P Acyinena; Patrick Shannon; Diane Myles-Reid; Susan Blaser; Tim V Mieghem; Halenur Yavuz-Kienle; Heyko Skladny; Kristen Miller; Miereia D T Riera; Silvia A Martínez; Eduardo F Tizzano; Lucie Dupuis; Dimitri James Stavropoulos; Vanda McNiven; Roberto Mendoza-Londono; Alison M Elliott; Robert S Phillips; Gavin Chapman; Sally L Dunwoodie
Journal:  Hum Mutat       Date:  2021-05-16       Impact factor: 4.700

4.  Extreme pathway analysis reveals the organizing rules of metabolic regulation.

Authors:  Yanping Xi; Fei Wang
Journal:  PLoS One       Date:  2019-02-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.